Gregor Heiduschka

1.5k total citations
95 papers, 1.1k citations indexed

About

Gregor Heiduschka is a scholar working on Oncology, Molecular Biology and Otorhinolaryngology. According to data from OpenAlex, Gregor Heiduschka has authored 95 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Oncology, 37 papers in Molecular Biology and 35 papers in Otorhinolaryngology. Recurrent topics in Gregor Heiduschka's work include Head and Neck Cancer Studies (34 papers), Salivary Gland Tumors Diagnosis and Treatment (21 papers) and Cancer-related gene regulation (12 papers). Gregor Heiduschka is often cited by papers focused on Head and Neck Cancer Studies (34 papers), Salivary Gland Tumors Diagnosis and Treatment (21 papers) and Cancer-related gene regulation (12 papers). Gregor Heiduschka collaborates with scholars based in Austria, Pakistan and Germany. Gregor Heiduschka's co-authors include Dietmar Thurnher, Markus Brunner, Boban M. Erović, Lorenz Kadletz, Sven Schneider, Johannes Pammer, Edgar Selzer, Bernhard J. Jank, Lukas Kenner and Rudolf Seemann and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Gregor Heiduschka

92 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gregor Heiduschka Austria 18 613 390 234 230 148 95 1.1k
Hai‐Qiang Mai China 16 297 0.5× 301 0.8× 193 0.8× 310 1.3× 172 1.2× 53 888
Satoru Sasaki Japan 14 164 0.3× 297 0.8× 407 1.7× 22 0.1× 231 1.6× 71 1.0k
Liang Peng China 16 251 0.4× 310 0.8× 165 0.7× 144 0.6× 149 1.0× 78 843
Cem Sezer Türkiye 17 232 0.4× 233 0.6× 197 0.8× 10 0.0× 93 0.6× 73 899
Bin Jiang China 23 387 0.6× 1.1k 2.9× 355 1.5× 29 0.1× 451 3.0× 57 2.0k
Jiaxin Lin China 18 699 1.1× 687 1.8× 107 0.5× 7 0.0× 400 2.7× 65 1.6k
Akihiro Miyazaki Japan 16 443 0.7× 449 1.2× 198 0.8× 145 0.6× 250 1.7× 89 1.3k
Xiong Peng China 18 134 0.2× 759 1.9× 167 0.7× 171 0.7× 529 3.6× 52 1.4k

Countries citing papers authored by Gregor Heiduschka

Since Specialization
Citations

This map shows the geographic impact of Gregor Heiduschka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregor Heiduschka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregor Heiduschka more than expected).

Fields of papers citing papers by Gregor Heiduschka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregor Heiduschka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregor Heiduschka. The network helps show where Gregor Heiduschka may publish in the future.

Co-authorship network of co-authors of Gregor Heiduschka

This figure shows the co-authorship network connecting the top 25 collaborators of Gregor Heiduschka. A scholar is included among the top collaborators of Gregor Heiduschka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gregor Heiduschka. Gregor Heiduschka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fuereder, Thorsten, Agmal Scherzad, Stephan Hackenberg, et al.. (2025). Monotherapy With Immune Checkpoint Inhibitors in Patients With Recurrent and/or Metastatic Sinonasal Squamous Cell Carcinoma. Cancer Medicine. 14(23). e71391–e71391.
2.
Heiduschka, Gregor, et al.. (2024). Lymphocyte-to-Monocyte Ratio Might Serve as a Prognostic Marker in Young Patients with Tongue Squamous Cell Carcinoma. Journal of Personalized Medicine. 14(2). 159–159. 1 indexed citations
3.
Brkic, Faris F., et al.. (2023). The ATR inhibitor berzosertib acts as a radio- and chemosensitizer in head and neck squamous cell carcinoma cell lines. Investigational New Drugs. 41(6). 842–850. 2 indexed citations
4.
Jank, Bernhard J., et al.. (2023). High USP4 mRNA is associated with an HPV-positive status in head and neck squamous cell carcinoma patients. Journal of Cancer Research and Clinical Oncology. 149(12). 10675–10683. 1 indexed citations
5.
Brkic, Faris F., et al.. (2023). β-CATENIN is a positive prognostic marker for HPV-positive head and neck squamous cell carcinoma. Journal of Cancer Research and Clinical Oncology. 149(10). 7743–7750.
7.
Jank, Bernhard J., et al.. (2023). Targeting TGF beta receptor 1 in head and neck squamous cell carcinoma. Oral Diseases. 30(3). 1114–1127. 4 indexed citations
8.
Faisal, Muhammad, Stefan Grasl, Johannes Pammer, et al.. (2023). Survival Outcome in True Carcinoma of Unknown Primary (tCUP) with p16 + Cervical Metastasis. International Archives of Otorhinolaryngology. 27(4). e687–e693. 1 indexed citations
10.
Brkic, Faris F., et al.. (2022). Targeting Wnt/Beta-Catenin Signaling in HPV-Positive Head and Neck Squamous Cell Carcinoma. Pharmaceuticals. 15(3). 378–378. 9 indexed citations
12.
Brkic, Faris F., et al.. (2021). The Potential Prognostic Value of a Novel Hematologic Marker Fibrinogen-to-Lymphocyte Ratio in Head and Neck Adenoid-Cystic Carcinoma. Journal of Personalized Medicine. 11(11). 1228–1228. 6 indexed citations
13.
Jank, Bernhard J., et al.. (2021). Prognostic Relevance of Thyroid-Hormone-Associated Proteins in Adenoid Cystic Carcinoma of the Head and Neck. Journal of Personalized Medicine. 11(12). 1352–1352. 3 indexed citations
14.
Schneider, Sven, et al.. (2020). Intraparotid and cervical lymph nodes metastasis in primary parotid gland carcinoma—impact on clinical outcome. Oral Surgery Oral Medicine Oral Pathology and Oral Radiology. 129(6). 570–574. 3 indexed citations
15.
Kadletz, Lorenz, Bernhard J. Jank, Felicitas Oberndorfer, et al.. (2020). Expression of inhibitors of apoptosis proteins in salivary gland adenoid cystic carcinoma: XIAP is an independent marker of impaired cause‐specific survival. Clinical Otolaryngology. 45(3). 364–369. 4 indexed citations
16.
Jank, Bernhard J., et al.. (2019). Prognostic value of advanced lung cancer inflammation index in head and neck squamous cell carcinoma. European Archives of Oto-Rhino-Laryngology. 276(5). 1487–1492. 20 indexed citations
17.
Kadletz, Lorenz, Faris F. Brkic, Bernhard J. Jank, et al.. (2019). AF1q Expression Associates with CD44 and STAT3 and Impairs Overall Survival in Adenoid Cystic Carcinoma of the Head and Neck. Pathology & Oncology Research. 26(2). 1287–1292. 3 indexed citations
18.
Brkic, Faris F., Lorenz Kadletz, Bernhard J. Jank, et al.. (2018). Pretreatment assessment of hematologic and inflammatory markers in adenoid cystic carcinoma: neutrophil/lymphocyte ratio is associated with multiple recurrences. Oral Surgery Oral Medicine Oral Pathology and Oral Radiology. 127(5). 408–416. 13 indexed citations
19.
Kadletz, Lorenz, Gregor Heiduschka, Axel Wolf, et al.. (2017). Effect of postoperative radiotherapy in pT1pN1cM0 and pT2p/cN0cM0 oropharyngeal squamous cell carcinoma. The Laryngoscope. 128(5). 1075–1082. 1 indexed citations
20.
Heiduschka, Gregor, Sohaib Virk, Carsten E. Palme, et al.. (2016). Margin to tumor thickness ratio – A predictor of local recurrence and survival in oral squamous cell carcinoma. Oral Oncology. 55. 49–54. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026